Center Overview

Baylor Research Institute Mission Statement:
To improve the medical care and well-being of our community-- nationally and internationally-- through innovative, clinically relevant research that is consistent with the mission, vision and values of Baylor Health Care System.

Established in 1984, Baylor Research Institute (BRI), an affiliate of Baylor Health Care System, has a network of over 3,000 board-certified physicians including approximately 250 active clinical research investigators, experienced in both drug and device studies. Serving more than 800,000 people at medical centers in Dallas, Fort Worth, Garland, Grapevine, Irving, Plano and Waxahachie, Baylor Health Care System offers a large and diverse pool of potential research participants.

Clinical Research Experience

As a leading clinical research institution, Baylor Research Institute offers our community the opportunity to participate in research trials across a wide spectrum of medical specialties, including:

• Asthma / Pulmonary
• Bone Marrow Transplant
• Cardiology
• Dermatology
• Endocrinology
• Gastroenterology
• Hepatology
• Interventional Radiology
• Immunology
• Metabolic Disease
• Nephrology
• Neurology
• OB/Neonatology
• Oncology
• Orthopaedics
• Rheumatology
• Transplantation
• Urology

Through clinical research, investigators achieve advances in medicine and bring innovative therapies to patients at Baylor Health Care System. Baylor Health Care System recruits leading physicians and scientists to enhance its scientific base and provide advanced patient therapies. Research keeps physicians on the forefront of medical knowledge. Investigators at Baylor Health Care System's medical centers publish research findings in top-tier medical journals, such as Science, The New England Journal of Medicine, Transplantation and Lancet. Baylor Health Care System also publishes Baylor University Medical Center Proceedings, a quarterly research journal detailing research and clinical activities at Baylor.

The institute staffs approximately 180 employees, including researchers, laboratory assistants and research coordinators. Michael Ramsay, M.D., serves as president of the Baylor Research Institute.

Facility Description

The following medical centers participate in research through Baylor Research Institute:

• Baylor All Saints Medical Center at Fort Worth
• Baylor Institute of Rehabilitation
• Baylor Medical Center at Garland
• Baylor Medical Center at Irving
• Baylor Medical Center at Southwest Fort Worth
• Baylor Regional Medical Center at Grapevine
• Baylor Regional Medical Center at Plano
• Baylor Specialty Hospital
• Baylor University Medical Center at Dallas
• Our Children's House at Baylor

These centers provide full-range, inpatient, outpatient, rehabilitation and emergency medical services through owned, leased or affiliated hospitals and surgical services at five short-stay hospitals.

Investigator Experience

Baylor Research Institute has approximately 250 active clinical trials investigators, experienced in both drug and device studies. Our Investigators specialize in the areas of Cardiology, Bone Marrow Transplant, Dermatology, Endocrinology, Gastroenterology, Hepatology, Immunology, Interventional Radiology, Metabolic Disease, OB/Neonatology, Nephrology, Neurology, Oncology, Orthopaedics, Pulmonology, Rheumatology, Solid Organ Transplants and Urology.

Staff Expertise

Baylor Research Institute employs over 60 clinical research professionals in positions including research nurse, clinical research coordinator and clinical research assistant. Over half of the research nurses and coordinators are Certified Clinical Research Coordinators. The research staff assists Baylor Health Care System investigators with coordinating and managing administrative and clinical aspects of investigational drug, device and other research trials. The research staff has experience managing Phase I through Phase IV clinical trials and is thoroughly educated in federal regulations and institutional policies.

Other Information

Baylor Research Institute received Full Accreditation from AAHRPP in December of 2003. The Office of Research Subject Protection at BRI has responsibility for the two Institutional Review Boards (IRBs), which meet monthly. There are approximately 630 active research projects involving human subjects being conducted under the auspices of the IRB.

Contact Information

Nanette Myers, MBA
BRI Business Development Specialist
Baylor Research Institute
3310 Live Oak, Suite 501
Dallas, TX 75204
USA
Phone: 214-820-9904
Fax: 214-820-4952
EMail: NanetteM@BaylorHealth.edu
Web Site: http://www.baylorresearchinstitute.com

Currently Enrolling Trials

• A multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy, safety and tolerability of taspoglutide (RO5073031) compared to placebo in obese patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy
• A randomized, double-blind, placebo-controlled, 2-arm parallel-group, multicenter study with a 24-week main treatment period and an extension assessing the efficacy and safety of AVE0010 on top of pioglitazone in patients with type 2 diabetes not adequately controlled with pioglitazone.
• The Use Of Etanercept for Treating Moderate to Severe Plaque Psoriasis
• Vaccination of HIV-1 infected patients with dendritic cells in addition to antiretroviral treatment - (DALIA Trial)

If you are interested in contacting this center to discuss placing a clinical trial there, please complete and send the E-mail form below. A representative from the research center will then follow up with you.